The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET
NCT00747968
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes
Interventions
DRUG:
Byetta, Exenatide
Sponsor
University of Aarhus
Collaborators
[object Object]
[object Object]